Clinical Trial: Clinical Study of UC-MSC Combined With Immunosuppressive Agents in the Treatment of Pediatric HAAA

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850362) titled 'Clinical Study of UC-MSC Combined With Immunosuppressive Agents in the Treatment of Pediatric HAAA' on Aug. 13, 2025.

Brief Summary: The goal of this clinical trial is to evaluate the effectiveness of umbilical cord mesenchymal stem cells combined with standard immunosuppressive therapy in children with HAAA, and to provide a new therapeutic idea for children with HAAA.

Whether UC-MSC combined with immunosuppressants can improve outcomes in children with HAAA.

Whether UC-MSC is safe in the treatment of children with HAAA.

Participants will:

1 Age < 18 years old, gender is not limited; 2 Diagnosis of hepatitis related aplastic ane...